Novartis AG EBIT 2010-2024 | NVS

Novartis AG EBIT for the quarter ending December 31, 2024 was $3.530B, a 36.72% increase year-over-year.

  • Novartis AG 2024 EBIT was 14.544B, a 48.88% increase from 2023.
  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.
  • Novartis AG 2022 EBIT was 7.946B, a 32.02% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Novartis AG EBIT 2010-2024 | NVS

  • Novartis AG 2024 EBIT was 14.544B, a 48.88% increase from 2023.
  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.
  • Novartis AG 2022 EBIT was 7.946B, a 32.02% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B